Company / PP&E per Share
NovoCure Ltd PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.72
FY2025
5-year range
$0.22 / $0.73
FY2021-FY2025
Trend
-1.4%
vs FY2024
Sector context
#103 of 133
Health Care
What the data says
NovoCure Ltd's pp&e per share of $0.72 is lower than 77% of companies in the Health Care sector (FY2025). Improved from $0.49 to $0.72 over the past 2 years.
Based on SEC 10-K filings.
0.72 in FY2025 with a 5-year CAGR of +44.3%.
Improved from $0.49 to $0.72 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +31.5%
- 5-Year CAGR
- +44.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 23% in Health CareTop 77% of 133This company $0.72 Sector average $11.64
▼
-93.9% below sector average
Key checks
Key Insights
- In FY2025, pp&e per share decreased 1.4% year-over-year.
- Ranks #103 out of 133 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2024.
- Lowest pp&e per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.72 | -1.4% |
| FY2024 | $0.73 | +48.0% |
| FY2023 | $0.49 | +55.9% |
| FY2022 | $0.31 | +41.7% |
| FY2021 | $0.22 | +93.7% |
| FY2020 | $0.11 | +14.3% |
| FY2019 | $0.10 | +6.2% |
| FY2018 | $0.09 | -9.0% |
| FY2017 | $0.10 | -11.4% |
| FY2016 | $0.12 | -76.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026